Denmark· DK-28105961717
Veyvondi
A von willebrand factor product containing vonicog alfa, registered in Denmark by Baxalta Innovations GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Von willebrand factor is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD10 (von willebrand factor), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Von willebrand factor · ATC B02BD10
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Vonicog alfa
- Manufacturer
- Baxalta Innovations GmbH
- Country
- Denmark (DK)
- ATC code
- B02BD10
- ATC class
- Von Willebrand factor
- Defined daily dose
- 1.5 TSD, E
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105961717
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for von willebrand factor.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Von willebrand factor · interactions on record
2 records
- 2 severe
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B02BD10
Von willebrand factor, as other registers publish it.
- NorwayVeyvondiBaxalta Innovations GmbH
- NorwayVeyvondiBaxalta Innovations GmbH
- IcelandVeyvondiBaxalta Innovations GmbH
- FinlandVeyvondiBaxalta Innovations GmbH
- IcelandVeyvondiBaxalta Innovations GmbH
- FinlandVeyvondiBaxalta Innovations GmbH
- DenmarkVeyvondiBaxalta Innovations GmbH
- PolandVEYVONDIBaxalta Innovations GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a8644fd1-6624-449a-b08b-6df7b131319a GET /v1/drugs/a8644fd1-6624-449a-b08b-6df7b131319a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver og solvens til injektionsvæske, opløsning",
"source": "dkma",
"strength": "1300 IE",
"auth_role": "MOD",
"dk_drugid": "28105961717",
"substance": "Vonicog alfa",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "43343"
}See everything about von willebrand factor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.